全文获取类型
收费全文 | 3085篇 |
免费 | 205篇 |
国内免费 | 60篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 44篇 |
妇产科学 | 7篇 |
基础医学 | 164篇 |
口腔科学 | 37篇 |
临床医学 | 481篇 |
内科学 | 1430篇 |
皮肤病学 | 47篇 |
神经病学 | 62篇 |
特种医学 | 33篇 |
外科学 | 89篇 |
综合类 | 249篇 |
预防医学 | 30篇 |
眼科学 | 18篇 |
药学 | 550篇 |
2篇 | |
中国医学 | 79篇 |
肿瘤学 | 19篇 |
出版年
2024年 | 8篇 |
2023年 | 53篇 |
2022年 | 41篇 |
2021年 | 136篇 |
2020年 | 115篇 |
2019年 | 115篇 |
2018年 | 117篇 |
2017年 | 86篇 |
2016年 | 75篇 |
2015年 | 81篇 |
2014年 | 172篇 |
2013年 | 242篇 |
2012年 | 145篇 |
2011年 | 127篇 |
2010年 | 110篇 |
2009年 | 76篇 |
2008年 | 107篇 |
2007年 | 103篇 |
2006年 | 102篇 |
2005年 | 79篇 |
2004年 | 81篇 |
2003年 | 75篇 |
2002年 | 72篇 |
2001年 | 61篇 |
2000年 | 67篇 |
1999年 | 54篇 |
1998年 | 55篇 |
1997年 | 54篇 |
1996年 | 61篇 |
1995年 | 45篇 |
1994年 | 62篇 |
1993年 | 46篇 |
1992年 | 49篇 |
1991年 | 65篇 |
1990年 | 51篇 |
1989年 | 46篇 |
1988年 | 48篇 |
1987年 | 44篇 |
1986年 | 34篇 |
1985年 | 33篇 |
1984年 | 45篇 |
1983年 | 24篇 |
1982年 | 16篇 |
1981年 | 17篇 |
1980年 | 9篇 |
1979年 | 13篇 |
1978年 | 8篇 |
1977年 | 4篇 |
1971年 | 5篇 |
1970年 | 3篇 |
排序方式: 共有3350条查询结果,搜索用时 445 毫秒
1.
2.
Sebastian P. Mondaca MD Dazhi Liu PharmD BCOP Jessica R. Flynn Sandy Badson Stefan Hamaway BS Mrinal M. Gounder MD Danny N. Khalil MD PhD Alexander E. Drilon MD Bob T. Li MD MPH Komal L. Jhaveri MD Alison M. Schram MD Katherine E. Kargus RN Mary Kate Kasler DNP MSN Natalie M. Blauvelt Neil H. Segal MD PhD Marinela Capanu PhD Margaret K. Callahan MD PhD David M. Hyman MD Maya Gambarin-Gelwan MD James J. Harding MD 《Cancer》2020,126(22):4967-4974
3.
目的观察老年中度和重度心力衰竭伴快速房性心律失常(包括心房颤动和心房扑动)患者静脉注射地尔硫控制心室率的有效性和安全性。方法选取NYHAⅢ、Ⅳ级的中、重度心力衰竭伴快速房性心律失常的老年患者,给予地尔硫静脉注射,观察有效率及血压、症状和体征变化。结果85例患者入选,80例(94.1%)患者有效,心室率由用药前的(149.5±18.2)次/分下降至用药结束时的(95.3±17.5)次/分,下降幅度36.2%,平均起效时间(6.3±3.9)分钟,用药前后心室率下降有显著意义(P<0.001)。所有患者血压均有下降但多在正常范围,有5例出现低血压,1例出现Ⅰ度房室传导阻滞伴窦性心动过缓,无1例出现心功能恶化。结论静脉注射地尔硫能迅速有效地控制中重度心力衰竭伴快速房性心律失常的老年患者的快速心室率,而且安全性高。 相似文献
4.
Hiroshi Morita MD Douglas P. Zipes MD Shiho T. Morita MD Jiashin Wu PhD 《Heart rhythm》2007,4(1):66-74
BACKGROUND: The Brugada syndrome is characterized by ST-segment elevation on the ECG, especially in the right precordial leads sensitive to the right ventricular outflow tract (RVOT). OBJECTIVES: The purpose of this study was to evaluate the hypothesis that right ventricular electrophysiologic heterogeneity caused arrhythmogenicity in the Brugada syndrome. METHODS: Action potentials (APs) were mapped on the epicardium of 14 RVOT preparations and on the transmural surfaces of 15 pairs of RVOT and right ventricular anteroinferior (RVAI) preparations isolated from canine hearts. Brugada ECG and arrhythmias were induced with pilsicainide (2.5-12.5 micromol/L), pinacidil (1.25-12.5 micromol/L), and terfenadine (2.0 micromol/L). RESULTS: Low doses of drugs elevated the J-ST segment and induced APs with both short and long action potential durations (APDs) in contiguous RVOT epicardial regions. In addition, APs in the RVOT had a larger phase 1 notch and longer APD than in RVAI. The longest APDs were in the epicardium in RVOT but in the endocardium in RVAI regions. High doses of drugs eliminated the phase 2 dome of the AP and abbreviated APDs in the epicardium but not in endocardium and reduced the epicardial heterogeneity of APs but increased the transmural gradient of APD in 14 (93%) of the RVOT preparations. In contrast, abbreviations of epicardial APDs occurred in only 4 (27%) of the RVAI preparations. Ventricular tachycardia occurred more frequently in the RVOT (47%) than in paired RVAI preparations (7%). Blocking the transient outward current reduced the heterogeneity of APs and eliminated arrhythmogenicity in all preparations. CONCLUSION: Compared with the RVAI region, the RVOT has greater electrophysiologic heterogeneity that contributes to arrhythmogenicity in this model of Brugada syndrome. 相似文献
5.
J. W. G. Tiller K. P. Maguire B. M. Davies J. T. Dowling L. H. Tung M. J. Rand 《Human psychopharmacology》1990,5(4):313-321
Five out of 12 physically healthy patients with depression undergoing a tyramine pressor test developed cardiac arrhythmias. These arrhythmias occurred in drug-free patients in three out of 12 infusions following as little as 0.03 mg/kg of tyramine and after moclobemide, a reversible inhibitor of monoamine oxidase-A, in four out of 14 tyramine infusions with as little as 0.04 mg/kg of tyramine. The arrhythmias seen were independent of patient's age and occurred both before and after 30 mmHg elevations in systolic blood pressure. Electrocardiographic abnormalities and arrhythmias seen were a loss of p waves, sinus tachycardia, frequent atrial ectopic beats, atrial premature beats, Wenckebach phenomenon, junctional rhythm, ventricular ectopics, varying QRS configurations, and ventricular bigeminy. Tyramine, both oral and intravenous, caused similar reproducible changes in dogs, though not in rats, mice or guinea pigs. Practical implications are that tyramine pressor testing in humans should be performed cautiously and only with adequate cardiac monitoring and resuscitation facilities at hand. These findings suggest that a normal dietary component can induce serious cardiac arrhythmias, and that a low-tyramine diet may be of value for patients who are susceptible to cardiac arrhythmias. 相似文献
6.
7.
8.
Although cardiac arrhythmias remain a serious clinical problem in many patients with heart disease, the exact role of antiarrhythmic drug therapy is currently under intense evaluation. Within the last several years it has become clear that there are significant risks as well as potential benefits associated with existing agents. Ongoing studies in large patient populations should help determine the benefit/risk ratio of traditional therapy. Regardless of the outcome of these trials, current electrophysiological dogma will have to be re-evaluated and newer concepts evolve for drug development to make further progress. The goal of this symposium is to exchange information among basic and clinical investigators so as to facilitate the emergence of novel electrophysiological concepts that will form the basis for future generations of antiarrhythmic drugs. 相似文献
9.
Prof. Dr. W. Bernauer 《Basic research in cardiology》1991,86(1):1-10
Summary In isolated perfused rat hearts global ischemia for 2, 5, and 15 min was produced. Depending on the duration of the ischemia, postischemic reperfusion led to the release of adenosine and its catabolites, and to more or less severe ventricular tachyarrhythmias. When ventricular fibrillation occurred, a highly significant increase in the purine release was observed compared with non-fibrillating hearts. Prevention of fibrillation by antiarrhythmic drugs decreased the purine release in a highly significant way. After only 2 min of ischemia, reperfusion did not lead to ventricular fibrillation. Electrical induction of fibrillation during the reperfusion in these hearts provoked the release of very high amounts of the purine compounds. A similar effect of electrically-induced fibrillation was also obtained in hearts without a previous ischemic period. The findings suggest that ventricular fibrillation is able to induce the release of purine derivatives from the heart. 相似文献
10.
清宫止血颗粒防治药流后阴道出血的临床观察附:178例病例报告 总被引:1,自引:1,他引:0
目的:探寻防治药流后阴道不规则出血的有效、低毒新药,为进一步推广此法扫清障碍。方法:将符合诊断和入选标准的药流后阴道不规则出血、并自愿参予本课题临床试验的178例受试者分为3组,即:清宫止血颗粒治疗组(66例)、益母草对照组(59例)和空白对照组(53例),在严密观察和保证安全的前提下进行试验。前2组在接受药流后分别服用清宫止血颗粒、益母草冲剂治疗,空白对照组则不服用任何药物,观察其自然恢复过程。结果:清宫颗粒组受试者其出血时间短于其余2组(P<0.0l或P<0.05);其出血量少于其余2组(P<0.0l或P<0.05);其完全流产率高于其余2组(P<0.0l或P<0.05);其月经恢复时间短于其余2组(P<0.0l或P<0.05)。结论:清宫止血颗粒对药流后不规则阴道出血有良好的防治作用,其疗效优于益母草冲剂。 相似文献